5 Biggest European Pharmaceutical Companies

2. Novo Nordisk A/S (NYSE:NVO)

Market Capitalization as of November 22, 2022: $257 billion

Novo Nordisk A/S (NYSE:NVO) is a Danish healthcare company. It offers treatments for obesity, diabetes, growth disorders, and haemophilia, among others.

Novo Nordisk A/S (NYSE:NVO) announced in November 2022 that it will spend DKK5.4 billion to expand its drug production in Denmark. The facility will be up by 2024, and it will provide active pharmaceutical ingredients for the firm’s clinical trials. Research firm GlobalData expects that Novo Nordisk A/S (NYSE:NVO)’s diabetes treatments grew their sales by 44% annually for the first three quarters of this year.

By the end of this year’s third quarter, 40 out of the 920 hedge funds part of Insider Monkey’s research had bought Novo Nordisk A/S (NYSE:NVO)’s shares. Jim Simons’ Renaissance Technologies is Novo Nordisk A/S (NYSE:NVO)’s largest investor. It owns 15 million shares worth $1.5 billion.